title: Cost-benefit evaluation of on-farm milk progesterone testing to monitor return to cyclicity and to classify ovarian cysts.
abstract: The effect of using on-farm milk progesterone testing to monitor return to cyclicity after parturition and to classify correctly and to treat cystic cows was evaluated using modeling and simulation. The test was evaluated assuming low and high accuracies of progesterone measurement, first breeding policy of 40 d, average estrus detection rate of 55%, and an average fertility rate of 55%. Three testing schemes (starting milk progesterone testing on d 30, 40, or 50 after parturition) were compared against a control to evaluate the effect of monitoring return to cyclicity on cows' reproductive and economic performance. For this purpose, the use of the test was an economically justifiable management intervention. Starting to test on d 30 after parturition was the most effective scheme, reducing days open by 18 d, replacement rate by 2.4%, and increasing net return per cow per year by $11. Starting to test on d 50 postpartum was not economically justifiable. Accuracy of the test, within the range used in this study, was unimportant. Testing was most profitable in herds with low fertility and low efficiency of estrus detection. The use of the test to classify follicular and luteal cysts and to select the appropriate therapy was not economically justifiable because of the low proportion of cystic cows and the high variation in response to therapy.
authors.affiliation: Department of Animal Science, Cornell University, Ithaca, NY 14853.
authors.forename: F J
authors.initials: FJ
authors.lastname: Ruiz
authors.forename: P A
authors.initials: PA
authors.lastname: Oltenacu
authors.forename: R D
authors.initials: RD
authors.lastname: Smith
mesh_terms: D000818:Animals; D002417:Cattle / Q000502:physiology*; D002418:Cattle Diseases / Q000175:diagnosis* / Q000188:drug therapy; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D003612:Dairying / Q000191:economics; D004972:Estrus Detection / Q000379:methods; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D008892:Milk / Q000032:analysis*; D008954:Models, Biological; D010048:Ovarian Cysts / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D049590:Postpartum Period / Q000502:physiology; D011374:Progesterone / Q000032:analysis*; D012680:Sensitivity and Specificity
chemical_list: D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone